Medicine

All Articles

A chatbot transforms the minds of conspiracy theory thinkers

.RESEARCH STUDY HIGHLIGHT.14 October 2024.

A research of over 2,000 folks shows that engaging alo...

How to create cardiology scientific tests much more inclusive #.\n\nVilcant, V., Ceron, C., Verma, G., Zeltser, R. &amp Makaryus, A. N. Addition of under-represented ethnological and also nationalities in cardio professional trials. Cardiovascular System Bronchi Circ. 31, 1263\u00e2 $\" 1268 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFilbey, L. et al. Improving representativeness in trials: a call to activity coming from the International Cardiovascular Clinical Trialists Discussion Forum. Eur. Center J. 44, 921\u00e2 $\" 930 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nJin, X. et cetera. Women\u00e2 $ s engagement in cardio professional tests coming from 2010 to 2017. Flow 141, 540\u00e2 $\" 548 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nCholesterol Levels Therapy Trialists\u00e2 $ Partnership Effectiveness as well as safety and security of statin treatment in older individuals: a meta-analysis of personal participant data from 28 randomised measured tests. Lancet 393, 407\u00e2 $\" 415 (2019 ). Au, M. et al. A step-by-step evaluation of sex-specific reporting in heart failure clinical trials: trial circulation and also outcomes. J. Am. Coll. Cardiol. Adv. 1, 100079 (2022 ).\nGoogle Scholar\u00c2.\nWei, S. et al. Elements related to genetic and also ethnic diversity amongst cardiac arrest test individuals: a methodical bibliometric evaluation. Circ. Center Fail. 15, e008685 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nTahhan, A. S. et cetera. Application of older people, women, and racial\/ethnic adolescence groups in present-day acute coronary syndrome professional trials: a systematic review. JAMA Cardiol. 5, 714\u00e2 $\" 722 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nCherubini, A. et al. The constant exclusion of more mature clients due to recurring medical tests relating to heart failure. Arc. Trainee. Med. 171, 550\u00e2 $\" 556 (2011 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMichos, E. D. &amp Vehicle Spall, H. G. C. Boosting portrayal and also range in cardiovascular scientific trial populaces. Nat. Rev. Cardiol. 18, 537\u00e2 $\" 538 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNational Academies of Sciences, Design, and also Medicine. Improving Depiction in Professional Tests and Research Study: Property Investigation Equity for Women and also Underrepresented Teams (eds Bibbins-Domingo, K. &amp Helman, A.) (National Academies Press, 2022). Packer, M. et al. Cardiovascular and renal end results with empagliflozin in cardiac arrest. N. Engl. J. Medication. 383, 1413\u00e2 $\" 1424 (2020 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nZannad, F. et al. SGLT2 inhibitors in patients with heart failure along with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced as well as DAPA-HF trials. Lancet 396, 819\u00e2 $\" 829 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nLam, C. S. P. et al. Regional as well as cultural influences on the action to empagliflozin in people along with cardiac arrest and also a lowered ejection fraction: the EMPEROR-Reduced test. Eur. Center J. 42, 4442\u00e2 $\" 4451 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nRathore, S. S., Wang, Y. &amp Krumholz, H. M. Sex-based differences in the result of digoxin for the therapy of cardiac arrest. N. Engl. J. Medication. 347, 1403\u00e2 $\" 1411 (2002 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nMihan, A., Pandey, A. &amp Truck Spall, H. G. C. Relieving the risk of artificial intelligence predisposition in heart care. Lancet Digit. Wellness https:\/\/doi.org\/10.1016\/S2589-7500( 24 )00155-9 (2024 ). Bodicoat, D. H. et cetera. Marketing addition in professional trials\u00e2 $\" a quick testimonial of the literary works and suggestions for action. Tests 22, 880 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGoldberg, E. M. et cetera. Making use of social networks for professional research: suggestions as well as instances coming from the Brown-Lifespan Center for Digital Health. J. Med. Net Res. 24, e35804 (2022 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nMihan, A. &amp Vehicle Spall, H. G. C. Interventions to enrich digital health equity in cardio care. Nat. Med. 30, 628\u00e2 $\" 630 (2024 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFultinavi\u00c4 i\u00c5\" t\u00c4 --, U. artificial intelligence perks in client id as well as scientific trial recruitment possesses problems visible. Scientific Trials Sector https:\/\/www.clinicaltrialsarena.com\/features\/ai-clinical-trial-recruitment\/ (2022 ). Grover, N. &amp Coulter, M. Idea: big pharma bets on AI to accelerate professional trials. News agency https:\/\/www.reuters.com\/technology\/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22\/ (2023 ). Kretschmer, M., Kretschmer, T., Peukert, A. &amp Peukert, C. The risks of risk-based AI requirement: taking obligation seriously. SSRN https:\/\/doi.org\/10.2139\/ssrn.4622405 (2023 ). Strumberger, S. EU AI Act: the current updates on the world\u00e2 $ s initially comprehensive AI law laws. Thomson Reuters https:\/\/legalsolutions.thomsonreuters.co.uk\/blog\/2023\/12\/12\/ai-act-the-worlds-first-comprehensive-laws-to-regulate-ai\/

:~:text=In%20April%202021%2C%20the%20European,mean%20more%20or%20less%20regulation (2024 ). Ali, M. ...

To conquer antimicrobial protection in Africa, create local capacity

.Rises in antimicrobial protection around the world are actually most likely to reach African countr...

Lessons from a negative gene treatment trial for Duchenne muscular dystrophy

.Nature Medicine, Published online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxep...

People along with heart pacemakers need multidisciplinary treatment

.Attribute Medicine, Posted online: 09 October 2024 doi:10.1038/ s41591-024-03296-wEchocardiographic...

AAV gene treatment for Duchenne muscle dystrophy: the EMBARK phase 3 randomized trial

.Trial oversightThis test was carried out in accordance with the arrangements of the Affirmation of ...

Computational human brain models map variety ingrained in getting older as well as dementia

.Publisheru00e2 $ s note Springer Nature continues to be neutral when it come to administrative clai...

Lassa vaccinations to save lifestyles, spare economic conditions as well as support in widespread readiness

.Publisheru00e2 $ s keep in mind Springer Attributes continues to be neutral when it come to jurisdi...

Putting children\u00e2 $ s safety at the center of brutality research

.We thank our associates who are analysts, system implementors, social employees, plan makers commit...

Author Correction: MDMA-assisted treatment for moderate to severe post-traumatic stress disorder: a randomized, placebo-controlled period 3 trial

.A list of members as well as their affiliations appears in the Supplementary Information.Neuroscape...